BETTER CELLS FOR BETTER THERAPIES Trademark

Trademark Overview

On Friday, January 8, 2016, a trademark application was filed for BETTER CELLS FOR BETTER THERAPIES with the United States Patent and Trademark Office. The USPTO has given the BETTER CELLS FOR BETTER THERAPIES trademark a serial number of 86984029. The federal status of this trademark filing is REGISTERED as of Tuesday, September 4, 2018. This trademark is owned by Fate Therapeutics, Inc.. The BETTER CELLS FOR BETTER THERAPIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy research, disease model systems research, and drug discovery and development; medical laboratory research; research, namely, scientific research; medical and scientific research, namely, conducting pre-clinical and clinical trials
better cells for better therapies

General Information

Serial Number86984029
Word MarkBETTER CELLS FOR BETTER THERAPIES
Filing DateFriday, January 8, 2016
Status700 - REGISTERED
Status DateTuesday, September 4, 2018
Registration Number5556215
Registration DateTuesday, September 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2016

Trademark Statements

Goods and ServicesMedical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy research, disease model systems research, and drug discovery and development; medical laboratory research; research, namely, scientific research; medical and scientific research, namely, conducting pre-clinical and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 15, 2016
Primary Code042
First Use Anywhere DateMonday, January 11, 2016
First Use In Commerce DateMonday, January 11, 2016

Trademark Owner History

Party NameFate Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, April 26, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2016NEW APPLICATION ENTERED
Friday, January 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 25, 2016ASSIGNED TO EXAMINER
Tuesday, April 26, 2016NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION WRITTEN
Wednesday, September 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, October 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2016PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 12, 2017SOU TEAS EXTENSION RECEIVED
Monday, June 12, 2017SOU EXTENSION 1 FILED
Wednesday, January 10, 2018SOU EXTENSION 2 FILED
Monday, June 12, 2017SOU EXTENSION 1 GRANTED
Wednesday, June 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018DIVISIONAL REQUEST RECEIVED
Wednesday, January 10, 2018SOU EXTENSION 2 GRANTED
Friday, January 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 10, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, July 10, 2018TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, July 10, 2018USE AMENDMENT FILED
Monday, July 30, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 30, 2018DIVISIONAL PROCESSING COMPLETE
Monday, July 30, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 26, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, September 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 31, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 1, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 4, 2018REGISTERED-PRINCIPAL REGISTER

Related Keywords

better therapies cells research medical clinical namely scientific stem development field drug discovery